Invitae | Sustainability Performance
Provides genetic testing services with applications in hereditary disease screening, oncology, and reproductive health. Its platforms analyze DNA to deliver clinical insights for patients and healthcare providers. The company emphasizes integration of genetic information into medical decision-making.
2010
United States
1,001 - 5,000 employees
Biotechnology
$500M - 1B in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#9424
Overall#2110
in United States#197
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$516.0MFY2022 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
77.9%FY2022
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-182.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.3
▼ 2.1%
0.5
▼ 3.3%
0.5
▼ 2.8%
0.6
2026Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Available
Recycling policy
Not available
Workplace health & safety policy
Available
44%
Independent Directors
7 out of 16 incl. management
Overall score
58
Environment
46
Social
77
Governance
51
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
